Depixus will be participating in the 6th Annual RNA-Targeted Drug Discovery Summit from 12 to 14 December, 2023, Boston, USA.
As one of the most anticipated events on the RNA calendar, the RNA-Targeted Drug Discovery Summit returns this December. This premier, definitive, and most comprehensive forum for the RNA-targeting small molecule community will address remaining challenges, including but not limited to RNA structure and function relationship, functional validation, and the translational route from discovery to pre-clinical and clinical development.
Dr Pascal Beurdeley, SVP Product Development, will be talking about how Depixus is accelerating the discovery of such novel therapeutics using its powerful new MAGNA™ technology. Don’t miss her presentation, which is entitled ‘Structure-activity relationships: using magnetic force spectroscopy to link in vivo and in vitro data in RNA-targeted small molecule drug discovery.’
Also, Dr Adeline Feri (Principal Scientist, Product Development) will be presenting a poster entitled ‘Single molecule real-time analysis of dynamic nucleic acid interactions’.
We look forward to meeting you there!